HealthCor Catalio Acquisition Corp. announced the pricing of its $180 million IPO this evening and its shares are expected to begin trading on the Nasdaq under the symbol “HCAQ” Wednesday, January 27.
The new company aims to combine with a business in the US healthcare industry, particularly the life sciences and medical technology sectors. HealthCor is led by CEO Christopher Gaulin, CFO Christine Clarke, President George Petrocheilos, and Chairman Joseph Healey.
Total SPAC deal count for 2021 year-to-date is now 78 with $22.2 billion in gross proceeds raised. This offering is expected to close on Friday, January 29.
Jefferies LLC is serving as the sole book-running manager for the offering. Kirkland & Ellis LLP is serving as Issuer’s Counsel with Paul Hastings LLP serving as Underwriter’s Counsel. Marcum LLP serves as auditor. Continental Stock Transfer & Trust Company is acting as trustee.